B Mirror Report :  Capital market–listed company Indo-Bangla Pharmaceuticals Limited has published its unaudited financial report for the first quarter (July ’25–September ’25) ended on 30 September 2025. Although the company incurred a loss in the same period last year, it recorded earnings per share in the reported quarter.

The report was disclosed after being reviewed and approved at a meeting of the company’s Board of Directors held on Thursday (15 January), according to DSE sources.

According to the sources, in the first quarter of the current financial year the company earned 1 paisa per share. In the same period last year, the company incurred a loss of 3 paisa per share.

In the first quarter of the current financial year, the company’s cash flow per share was 2 paisa, compared to minus 6 paisa in the same period last year.

As of 30 September 2025, the company’s net asset value per share (NAVPS) stood at Tk 12.54.